BioCentury
ARTICLE | Financial News

Aadi raises $23M in series A

May 12, 2017 3:56 AM UTC

On May 8, cancer company Aadi Bioscience Inc. (Pacific Palisades, Calif.) raised $23 million in a series A round led by Hermed Capital. Celgene Corp. (NASDAQ:CELG), Vivo Capital, Decheng Capital, Hel...